MTDH associates with m6A RNA methylation and predicts cancer response for immune checkpoint treatment

Immune checkpoint blockade (ICB) persistently provides a prognosis improvement but only in a small fraction of patients with cancer due to immunotherapy resistance induced by the consecutive activated oncogenic pathways, including MAPK, Akt, and WNT pathway partially driven by Metadherin (MTDH). How...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fen, Huang, Huimei, Qin, Yuexiang, Chen, Changhan, She, Li, Wang, Juncheng, Huang, Donghai, Tang, Qinglai, Liu, Yong, Zhu, Gangcai, Zhang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479698/
https://www.ncbi.nlm.nih.gov/pubmed/34622157
http://dx.doi.org/10.1016/j.isci.2021.103102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479698/
https://www.ncbi.nlm.nih.gov/pubmed/34622157
http://dx.doi.org/10.1016/j.isci.2021.103102

Ejemplares similares